Medical Journals

Glycosphingolipid-facilitated Membrane Insertion and Internalization of Cobra Cardiotoxin. The Sulfatide.cardiotoxin Complex Structure in a Membrane-like Environment Suggests a Lipid-dependent Cell-penetrating Mechanism for Membrane Binding Polypeptides.

Authors:
  • Wang Chia-Hui
  • Liu Jyung-Hurng
  • Lee Shao-Chen
  • Hsiao Chwan-Deng
  • Wu Wen-Guey

From: Department of Life Sciences and Institute of Bioinformatics and Structural Biology, National Tsinghua University, Hsinchu, Taiwan 30013, Republic of China.

The Journal of biological chemistry

  • Publish Date: Jan 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 1
  • Pages: 656-67
  • Medium: Print
  • Language: English
  • Citation (JAMA): Wang Chia-Hui, Liu Jyung-Hurng, Lee Shao-Chen, et al. Glycosphingolipid-facilitated Membrane Insertion and Internalization of Cobra Cardiotoxin. The Sulfatide.cardiotoxin Complex Structure in a Membrane-like Environment Suggests a Lipid-dependent Cell-penetrating Mechanism for Membrane Binding Polypeptides.. J. Biol. Chem. Jan 2006;281:656-67

Abstract

Cobra cardiotoxins, a family of basic polypeptides having lipid- and heparin-binding capacities similar to the cell-penetrating peptides, induce severe tissue necrosis and systolic heart arrest in snakebite victims. Whereas cardiotoxins are specifically retained on the cell surface via heparan sulfate-mediated processes, their lipid binding ability appears to be responsible, at least in part, for cardiotoxin-induced membrane leakage and cell death. Although the exact role of lipids involved in toxin-mediated cytotoxicity remains largely unknown, monoclonal anti-sulfatide antibody O4 has recently been shown to inhibit the action of CTX A3, the major cardiotoxin from Taiwan cobra venom, on cardiomyocytes by preventing cardiotoxin-induced membrane leakage and CTX A3 internalization into mitochondria. Here, we show that anti-sulfatide acts by blocking the binding of CTX A3 to the sulfatides in the plasma membrane to prevent sulfatide-dependent CTX A3 membrane pore formation and internalization. We also describe the crystal structure of a CTX A3-sulfatide complex in a membrane-like environment at 2.3 angstroms resolution. The unexpected orientation of the sulfatide fatty chains in the structure allows prediction of the mode of toxin insertion into the plasma membrane. CTX A3 recognizes both the headgroup and the ceramide interfacial region of sulfatide to induce a lipid conformational change that may play a key role in CTX A3 oligomerization and cellular internalization. This proposed lipid-mediated toxin translocation mechanism may also shed light on the cellular uptake mechanism of the amphiphilic cell-penetrating peptides known to involve multiple internalization pathways.

Mesh Headings (Keywords): Animals, Antibodies, Cell Membrane, Cells, Cultured, Cobra Cardiotoxin Proteins, Dimerization, Lipid Bilayers, Membrane Potentials, Membrane Proteins, Myocytes, Cardiac, Patch-Clamp Techniques, Protein Structure, Quaternary, Protein Structure, Tertiary, Rats, Rats, Wistar, Sulfoglycosphingolipids


Check for Full Text / PubMed Unique Identifier (PMID): 16263708


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.